We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Breathe Easy

Webinar

 
Breathe Easy
 

This webinar will address key questions such as, what are the novel analytical methods relevant to OINDP in vitro bioequivalence studies? Also, what supporting evidence can be generated to aid formulation optimization and therefore help speed successful product development and regulatory submission? 

This webinar, led by OINDP experts from Aptar Pharma companies Next Breath and Nanopharm, will examine the analytical methods and regulatory frameworks associated with ensuring and establishing bioequivalence. 

The presenters will discuss the multiple, sometimes interconnected, strategies for reducing cycle times for OINDP development projects and how such strategies can be implemented in a practical way. In addition, technologies such as utilization of component-specific morphological methods will be highlighted as a means to advance OINDP development.

 
 
 
 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE